This page collects WhisperX intelligence signals tagged #FDA Approval. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to AKY-1189, an investigational therapeutic agent utilizing the alpha-emitting radioisotope actinium-225 (225Ac). This designation is specifically for the treatment of urothelial cancer, a type of cancer that begins in the urothelial cells l...
Kyverna Therapeutics is preparing to challenge the established boundaries of cell therapy, announcing plans to seek FDA approval for a personalized CAR-T treatment targeting stiff person syndrome—a rare and debilitating neurological autoimmune disorder. The company's one-time therapy demonstrated significant improvemen...
The Trump administration on Thursday announced completion of a landmark pricing agreement with Regeneron Pharmaceuticals, marking what the White House described as the culmination of its first round of pharmaceutical negotiating deals. The announcement positions the Regeneron accord as the final piece of an initial bat...